UC research targets dozens of incurable diseases
university-of-canterbury
Mon Feb 20 2017 13:00:00 GMT+1300 (New Zealand Daylight Time)
UC research targets dozens of incurable diseases
Monday, 20 February 2017, 10:56 am
Press Release: University of Canterbury
UC research targets dozens of incurable diseases
University of Canterbury researchers are working on a revolutionary drug-targeting system that could one day be used to treat a range of fatal, inherited diseases caused by genetic enzyme deficiencies.
With the aid of a Marsden Grant for $870,000, they’re focusing on around 60 or 70 incurable diseases called the lysosomal storage disorders, of which there are around 200 sufferers in New Zealand.
UC Chemistry Professor Antony Fairbanks says the system could deliver recombinant enzymes and other drugs to a specific organelle (a structure in a cell that performs a specialised function) within human cells, where they are needed.
“The key aspect of our research is to develop organelle targeting so we can specifically deliver enzymes and other drugs to where they need to be to do their job.”
Professor Antony Fairbanks, Biomolecular Interaction Centre/Chemistry, University of Canterbury, on his research project, A New Paradigm for Organelle Targeting:
ends
Advertisement - scroll to continue reading
Advertisement - scroll to continue reading
a.supporter:hover {background:#EC4438!important;} @media screen and (max-width: 480px) { #byline-block div.byline-block {padding-right:16px;}}
Using Scoop for work?
Scoop is free for personal use, but you’ll need a licence for work use. This is part of our Ethical Paywall and how we fund Scoop. Join today with plans starting from less than $3 per week, plus gain access to exclusive Pro features.
Join Pro Individual Find out more
Find more from University of Canterbury on InfoPages.